| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 30.124 | 31.686 | 45.139 | 31.456 | 35.054 | 30.762 | 64.380 | 81.580 | 105.595 | 77.073 |
| Total Income - EUR | 30.124 | 31.686 | 45.139 | 31.456 | 35.054 | 30.817 | 64.380 | 81.580 | 105.598 | 77.074 |
| Total Expenses - EUR | 17.958 | 12.838 | 25.948 | 22.992 | 29.960 | 20.018 | 22.484 | 34.934 | 97.800 | 73.729 |
| Gross Profit/Loss - EUR | 12.166 | 18.848 | 19.190 | 8.464 | 5.095 | 10.799 | 41.896 | 46.646 | 7.798 | 3.345 |
| Net Profit/Loss - EUR | 11.307 | 18.198 | 17.450 | 7.506 | 4.041 | 9.876 | 39.928 | 44.627 | 6.742 | 1.033 |
| Employees | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 2 | 2 |
Check the financial reports for the company - Cytogenis Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.854 | 2.606 | 37.928 | 33.512 | 35.787 | 31.929 | 28.968 | 22.871 | 52.717 | 38.534 |
| Current Assets | 36.699 | 56.415 | 38.941 | 23.431 | 27.866 | 38.995 | 80.210 | 96.921 | 63.344 | 52.127 |
| Inventories | 10.137 | 12.398 | 8.335 | 9.358 | 13.322 | 13.103 | 18.698 | 20.197 | 13.799 | 3.940 |
| Receivables | 1.280 | 2.461 | 2.736 | 3.662 | 4.186 | 5.219 | 5.462 | 19.828 | 36.603 | 38.519 |
| Cash | 25.282 | 41.556 | 27.871 | 10.411 | 10.358 | 20.673 | 56.050 | 56.896 | 12.942 | 9.667 |
| Shareholders Funds | 7.328 | 25.481 | 42.628 | 49.351 | 52.436 | 61.319 | 99.886 | 102.816 | 80.679 | 63.745 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 33.225 | 33.539 | 34.242 | 7.592 | 11.217 | 9.605 | 9.292 | 16.976 | 35.382 | 26.916 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cytogenis Srl